Alto Neuroscience (ANRO) vs OPKO Health (OPK)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Alto Neuroscience (ANRO) has outperformed OPKO Health (OPK) over the past year, gaining 304.8% versus a loss of 11.5%. OPKO Health is the larger company by market cap ($1.03 billion vs $956.3 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ANRO | OPK |
|---|---|---|
| Share price | $24.37 | $1.38 |
| Market cap | $956.33M | $1.03B |
| 1-day change | +1.41% | +0.73% |
| YTD return | +36.91% | +9.52% |
| 1-year return | +304.82% | -11.54% |
| 5-year return | — | -62.90% |
| EPS (TTM) | $-2.31 | $-0.09 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $37.48 | $1.75 |
| 52-week low | $5.23 | $0.98 |
| Distance from 52-week high | -34.98% | -21.14% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +57.49% | +217.39% |
| Average volume | 538.53K | 3.35M |
| Shares outstanding | 39.24M | 746.33M |
| Employees | 68 | 2,275 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ANRO has outperformed OPK by 316.4 percentage points over the past year.
About Alto Neuroscience
ANRO stock →Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 68 employees
About OPKO Health
OPK stock →OPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally.
Health Care · Biotechnology: Pharmaceutical Preparations · 2,275 employees
ANRO vs OPK FAQ
Which is bigger, Alto Neuroscience or OPKO Health?
OPKO Health (OPK) is larger, with a market capitalization of $1.03B compared with $956.33M for Alto Neuroscience (ANRO).
Which stock has performed better over the past year, ANRO or OPK?
ANRO returned +304.82% over the past 12 months, compared with -11.54% for OPK (price return, excluding dividends). Past performance does not predict future results.
Are Alto Neuroscience and OPKO Health in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.